cyclosporine , 12.5 mg/kg/day , was administered beginning on the day before marrow infusion and continued for 50 days , when it was tapered and discontinued by 6 months postgrafting . results were compared with data from concurrent and previously described patients receiving methotrexate as prophylaxis for graft-versus-host disease .
C0010592
cyclosporine
C0018133
graft-versus-host disease